Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | NERV | CPIX | IKT | ||
Company | Minerva Neuroscie | Cumberland Pharmaceu | Inhibikase Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.14 | 1.1000 | 1.9800 | ||
High | 2.23 | 1.1299 | 2.0300 | ||
Low | 2.14 | 1.0500 | 1.7500 | ||
Last | 2.21 | 1.0800 | 2.0100 | ||
Change | +0.09 | -0.0100 | +0.0300 | ||
% Change | +4.25% | -0.92% | +1.52% | ||
Volume | 17,700 | 28,100 | 257,100 | ||
20-Day Average Volume | 24,165 | 85,550 | 315,380 | ||
Previous Close | 2.12 | 1.0900 | 1.9800 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 2.33 | 1.1682 | 2.5000 | ||
20-Day Raw Stochastic | 18.39% | 8.57% | 13.40% | ||
20-Day Relative Strength | 39.91% | 34.88% | 47.00% | ||
Weighted Alpha | -33.10 | -44.64 | +11.98 | ||
Today's Opinion | 100% Sell | 100% Sell | 64% Buy | ||
Previous Opinion | 100% Sell | 100% Sell | 64% Buy | ||
Last Month's Opinion | 100% Sell | 100% Sell | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -4.74% since 11/14/24 | -10.00% since 11/14/24 | -14.83% since 11/14/24 | ||
Low | 2.07 on 11/18/24 | 1.0500 on 11/21/24 | 1.7500 on 11/21/24 | ||
High | 2.35 on 11/15/24 | 1.2000 on 11/15/24 | 2.3500 on 11/15/24 | ||
1-Month | |||||
%Chg | -13.16% since 10/21/24 | -11.48% since 10/21/24 | -9.46% since 10/21/24 | ||
Low | 2.07 on 11/18/24 | 1.0500 on 11/21/24 | 1.7500 on 11/21/24 | ||
High | 2.83 on 11/01/24 | 1.4000 on 10/28/24 | 3.6900 on 11/08/24 | ||
3-Month | |||||
%Chg | -16.92% since 08/21/24 | -22.30% since 08/21/24 | +38.62% since 08/21/24 | ||
Low | 2.07 on 11/18/24 | 1.0500 on 11/21/24 | 1.1200 on 09/25/24 | ||
High | 3.00 on 09/16/24 | 1.5099 on 09/30/24 | 3.6900 on 11/08/24 | ||
6-Month | |||||
%Chg | -10.16% since 05/21/24 | -34.55% since 05/21/24 | +6.35% since 05/21/24 | ||
Low | 2.07 on 11/18/24 | 1.0500 on 11/21/24 | 1.1200 on 09/25/24 | ||
High | 3.69 on 06/17/24 | 1.7300 on 05/22/24 | 3.6900 on 11/08/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 14,826 | 15,306 | 14,779 | ||
Shares Outstanding, K | 6,993 | 14,042 | 7,464 | ||
Annual Sales | 0 | 39,550,000 | 260,000 | ||
Annual Net Income | -30,010,000 | -6,280,000 | -19,030,000 | ||
Last Quarter Sales | 0 | 9,090,000 | 0 | ||
Last Quarter Net Income | 22,510,000 | -1,540,000 | -5,780,000 | ||
60-Month Beta | 0.18 | 0.22 | 1.11 | ||
Per-Share Information | |||||
Most Recent Earnings | 2.97 on 11/05/24 | -0.02 on 11/07/24 | -0.65 on 11/14/24 | ||
Latest Earnings Date | 11/05/24 | 11/07/24 | 11/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |